Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Interest & Investment Income: 2009-2025

Historic Interest & Investment Income for Amicus Therapeutics (FOLD) over the last 15 years, with Sep 2025 value amounting to $829,000.

  • Amicus Therapeutics' Interest & Investment Income fell 23.31% to $829,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 31.12%. This contributed to the annual value of $5.4 million for FY2024, which is 23.61% down from last year.
  • Per Amicus Therapeutics' latest filing, its Interest & Investment Income stood at $829,000 for Q3 2025, which was down 1.66% from $843,000 recorded in Q2 2025.
  • Amicus Therapeutics' 5-year Interest & Investment Income high stood at $2.2 million for Q1 2023, and its period low was $50,000 during Q2 2021.
  • In the last 3 years, Amicus Therapeutics' Interest & Investment Income had a median value of $1.4 million in 2024 and averaged $1.4 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 94.22% in 2021, then soared by 1,553.38% in 2023.
  • Quarterly analysis of 5 years shows Amicus Therapeutics' Interest & Investment Income stood at $186,000 in 2021, then spiked by 960.22% to $2.0 million in 2022, then declined by 15.26% to $1.7 million in 2023, then declined by 15.26% to $1.4 million in 2024, then fell by 23.31% to $829,000 in 2025.
  • Its Interest & Investment Income was $829,000 in Q3 2025, compared to $843,000 in Q2 2025 and $812,000 in Q1 2025.